eli lilly glp 1 New clinical trial data from shows its GLP-1 daily weight loss pill can reduce body weight by up to 11% over time. ABC News medical correspondent Dr. Darien Sutton joins Linsey Davis to Eli Lilly, GLP-1 Troubles Are
Description
New data is shedding light on a potential link between GLP-1 receptor agonists and long-term vision outcomes, with findings suggesting these therapies may be associated with a lower risk of legal blindness in patients with type 2 diabetes
This global initiative reframed obesity as a chronic, systemic disease rather than a mere risk factor
Here is what patients should know.
To jab or not to jab: Complicated questions of injections.
consider GNC, the vitamin and supplement retailer, which recently launched a telehealth service
others seek natural alternatives to the prescriptions
